WO2007010838A1 - Process for producing alkaline earth metal salt of (-)-hydroxycitric acid - Google Patents

Process for producing alkaline earth metal salt of (-)-hydroxycitric acid Download PDF

Info

Publication number
WO2007010838A1
WO2007010838A1 PCT/JP2006/314024 JP2006314024W WO2007010838A1 WO 2007010838 A1 WO2007010838 A1 WO 2007010838A1 JP 2006314024 W JP2006314024 W JP 2006314024W WO 2007010838 A1 WO2007010838 A1 WO 2007010838A1
Authority
WO
WIPO (PCT)
Prior art keywords
earth metal
alkaline earth
hydrate
metal salt
acid
Prior art date
Application number
PCT/JP2006/314024
Other languages
French (fr)
Japanese (ja)
Inventor
Shinji Yoshikawa
Shoichi Komai
Original Assignee
Nippon Shinyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co., Ltd. filed Critical Nippon Shinyaku Co., Ltd.
Priority to JP2007525985A priority Critical patent/JP4998264B2/en
Publication of WO2007010838A1 publication Critical patent/WO2007010838A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part

Definitions

  • the present invention relates to an alkaline earth metal salt (hereinafter referred to as "compound (1)”) represented by the following general structural formula (1): (1) -hydroxyquenic acid (hereinafter referred to as "HCA”) Or a new method for producing the hydrate.
  • compound (1) alkaline earth metal salt represented by the following general structural formula (1): (1) -hydroxyquenic acid (hereinafter referred to as "HCA”) Or a new method for producing the hydrate.
  • HCA is known as a substance abundant in the skin of Garcinia, and inhibits ATP citrate lyase, one of the enzymes on the pathway to synthesize citrate fat. It is known to be useful in the treatment of obesity because it suppresses the increase in fat mass (see, for example, Patent Document 1).
  • HCA can be obtained by extraction from the skin of Garcinia by the method of Lewis, YS, and the like, and its salt can be obtained from HCA by a conventional method (for example, , Non-Patent Document 1, Non-Patent Document 2, and Patent Document 2;).
  • HCA and its salts can be produced according to the method described in Patent Documents 3, 4, 5, 6, 7 in addition to the method of Lewis, Y. S. et al.
  • these methods cannot remove all impurities such as bectin and organic acids such as citrate, malic acid and tartaric acid, and it is difficult to produce high-purity HCA and the like.
  • the calcium salt of HCA can be produced by reacting an excess amount of calcium hydroxide with garcinia extract.
  • pectin contained in the extract forms a hard gel with calcium hydroxide. It is also known to obtain a high-purity substance because citrate and maleic acid form calcium salts that are sparingly soluble in water. It is difficult with the manufacturing method.
  • Patent Document 1 US Patent No. 3764692
  • Patent Document 2 Indian Patent No. 160753
  • Patent Document 3 Pamphlet of International Publication No. 99Z03464
  • Patent Document 4 US Patent No. 6875891
  • Patent Document 5 International Publication No. 2004Z100682 Pamphlet
  • Patent Document 6 US Pat. No. 6,160,172
  • Patent Document 7 European Patent No.866866
  • Non-patent literature l "Phytochemistry, 1965, 4 ⁇ , p. 619—625
  • Non-Patent Document 2 Lewis, Y. S. et al., “Methods In Enzymology”, 1969, 13 ⁇ , p. 613-617
  • An object of the present invention is mainly to provide a novel production method for obtaining a highly pure compound (1).
  • high purity means 96% or more, preferably 98% or more, and more preferably 99% or more.
  • compound (2) an alkaline earth metal salt of a rataton HCA represented by the following general structural formula (2), which is an intermediate of compound (1). Or a production method for easily obtaining the hydrate thereof with high purity.
  • Examples of the present invention include a method for producing compound (1) or a hydrate thereof having at least the following steps a to e.
  • Step b A step of depositing a product by leaving or cooling the reaction solution of Step a
  • Step c A step of obtaining the precipitate
  • Step d a step of reacting the obtained precipitate with an alkaline earth metal salt or hydrate thereof and a base
  • Step e A step of obtaining an alkaline earth metal salt of HCA or a hydrate thereof from the reaction solution in step d.
  • the present invention can include a method for producing compound (2) or a hydrate thereof having at least the following steps a 'to c'.
  • Step a Alkaline earth metal oxide or alkaline earth metal hydroxide in a range of 0.5 times or more and less than 0.9 times in molar ratio to Garcinia extract and HCA contained in Garcinia Reacting the product or its hydrate,
  • Step b ′ a step of depositing a product by leaving or cooling the reaction liquid in step a ′
  • step c ′ a step of acquiring the precipitate and recrystallizing the acquired precipitate.
  • Fig. 1 shows a chromatogram obtained by HPLC analysis.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • FIG. 2 Shows the chromatogram obtained by HPLC analysis.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • FIG. 3 Shows a chromatogram obtained by HPLC analysis.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • FIG. 4 A chromatogram obtained by HPLC analysis is shown.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • FIG. 5 A chromatogram obtained by HPLC analysis is shown. In the figure, the vertical axis represents time (minutes) and horizontal The axis indicates the absorption intensity.
  • FIG. 6 A chromatogram obtained by HPLC analysis is shown.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • FIG. 7 shows a chromatogram obtained by HPLC analysis.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • FIG. 8 shows a chromatogram obtained by HPLC analysis.
  • the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
  • Ganorescinia extract is an extract that contains a large amount of HCA. It can be obtained by performing an extraction operation.
  • Garcinia extract contains a small amount of strength, for example, polysaccharides such as pectin, and organic acids such as citrate, lingoic acid and tartaric acid. Even a garshi layer containing such impurities can be used in the present invention.
  • Garcinia extract is marketed as an aqueous solution containing HCA in the range of 10% to 70% by weight.
  • examples of such commercial products include Garcinia Extract S (manufactured by Nippon Shinyaku Co., Ltd.), Garcitric Gold (registered trademark) (manufactured by Renaissance Herb (USA), Citrin (registered trademark) (manufactured by Sabinsa (USA)). Citrimax (registered trademark) (manufactured by Interhealth (USA)).
  • the concentration of HCA contained in the garcinia extract is suitably within the range of 5% to 90% by weight, preferably within the range of 7% to 80% by weight, more preferably 10% to 70% by weight. Is within the range. If necessary, water may be added to adjust the concentration of HCA contained in the Garcinia extract.
  • Garcinia extract and alkaline earth metal hydroxide or alkaline earth metal hydroxide The reaction with the hydrate is carried out by, for example, stirring the garcinia extract and the alkaline earth metal oxide or alkaline earth metal hydroxide or hydrate in an aqueous solution while heating and stirring. Can be performed. At that time, if necessary, an appropriate amount of activated carbon may be added.
  • the “alkaline earth metal oxides” include acid calcium.
  • Examples of the “alkaline earth metal hydroxide or hydrate thereof” include calcium hydroxide or a hydrate thereof. Among these, calcium hydroxide dihydrate is particularly preferable.
  • the amount of the alkaline earth metal oxide or alkaline earth metal hydroxide or hydrate thereof is not particularly limited as long as the reaction solution does not show basicity.
  • the molar ratio with respect to HCA contained in the Garcinia extract is suitably in the range of 0.5 times or more and less than 0.9 times, preferably in the range of 0.7 times or more and less than 0.9 times, more preferably 0.
  • the amount of activated carbon used varies depending on the garcinia extract used, but is suitably in the range of 1 to 10% by weight with respect to the HCA contained in the garcinia extract, preferably 2 It is in the range of 7% by weight to 7% by weight, more preferably in the range of 3% to 4% by weight.
  • the reaction temperature varies depending on the concentration of HCA contained in the Garcinia extract and the amount of alkaline earth metal oxide or alkaline earth metal hydroxide used. Usually 20 ° C to 10 ° C
  • the range of 0 ° C is suitable, preferably within the range of 40 ° C to 95 ° C, more preferably 60 ° C.
  • reaction time varies depending on the reaction temperature, etc., it is suitable within the range of 1 minute to 24 hours.
  • This step can be performed, for example, by leaving the reaction solution of step a as it is at room temperature after completion of the reaction of step a. It can also be carried out by cooling the reaction solution in step a, and it is preferable to cool it rather than leaving it at room temperature.
  • the effective cooling temperature is usually in the range of 10 ° C to 30 ° C, preferably in the range of 5 ° C to 25 ° C. Within the range, more preferably within the range of 0 ° C to 20 ° C.
  • the cooling time is suitably in the range of 1 minute to 48 hours, preferably in the range of 10 minutes to 36 hours, and more preferably in the range of 20 minutes to 24 hours.
  • This step can be performed by performing a filtration operation by a conventional method.
  • the precipitates that can be produced in this step c are substantially free of impurities such as bectin, which is a polysaccharide, citrate, malic acid, tartaric acid, which are organic acids, which have been difficult to remove completely until now. Contained in a way.
  • This step can be carried out, for example, by dissolving the precipitate obtained in step c with heating in water, adding an alkaline earth metal salt or hydrate thereof and a base, and stirring with heating. If necessary, a filtering operation can be performed after adding the alkaline earth metal salt.
  • the amount of water used is, for example, suitably in the range of 5 to 100 times by weight with respect to the precipitate, preferably in the range of 10 to 70 times, more preferably 20 to 40 times. Within double range.
  • alkaline earth metal salts include calcium salts.
  • examples of the “calcium salt” include calcium chloride, calcium sulfate, calcium carbonate, and calcium bromide. Of these, calcium chloride dihydrate is particularly preferred.
  • the amount of the alkaline earth metal salt or hydrate thereof used is, for example, suitably in the range of 0.40 times to 0.70 times, preferably 0.45 times the molar ratio to the precipitate. Within the range of ⁇ 0.65 times, more preferably within the range of 0.50 times to 0.660 times.
  • base examples include amines such as aqueous ammonia, pyridine, and trimethylamine.
  • the amount of base used is, for example, suitably in the range of 0.5 to 2.0 times in molar ratio to the precipitate, preferably in the range of 0.9 to 1.5 times, More preferably, it is in the range of 1.0 times to 1.2 times.
  • the reaction temperature is usually within the range of 20 ° C to 100 ° C, preferably 30 ° C to 9 ° C. It is within the range of 5 ° C, more preferably within the range of 40 ° C to 90 ° C.
  • the reaction time varies depending on the reaction temperature and the like, but is suitably in the range of 1 minute to 12 hours, preferably in the range of 5 minutes to 7 hours, and more preferably in the range of 10 minutes to 2 hours.
  • the compound (1) in the reaction liquid in the step d can be obtained by performing a known solid-liquid separation operation.
  • the compound (1) can be washed with water.
  • the solid-liquid separation operation include a filtration operation, a dehydration operation using a centrifuge, or a juicer.
  • the compound (1) can be further purified. Specifically, the purity can be further increased by, for example, stirring the water of 10 to 20 times by weight with respect to the obtained compound (1) and performing the above solid-liquid separation operation. it can. If necessary, the mixture may be heated and stirred within a range of 40 ° C to 60 ° C.
  • the compound (1) obtained by performing the solid-liquid separation operation contains a large amount of water, it is preferable to perform a drying operation.
  • drying operation examples include drying under reduced pressure.
  • the vacuum force for example, 1. 0xl0 _13 Pa ⁇ l. 0xl0 5 Pa and is suitably within the range of, the good Mashiku 1. 0xl0 _9 Pa ⁇ l. 0xl0 4 within the Pa, more preferably 1. 0xl0 " 5 Pa ⁇ l. Within the range of 0xl0 3 Pa.
  • the drying temperature is, for example, suitably in the range of 50 ° C to 140 ° C, preferably in the range of 60 ° C to 130 ° C, more preferably in the range of 70 ° C to 120 ° C. .
  • the drying time is suitably in the range of 1 hour to 96 hours, preferably in the range of 12 hours to 72 hours, more preferably in the range of 24 hours to 48 hours.
  • step c the precipitate produced in step c from which impurities such as bectin, a polysaccharide, and organic acids such as citrate, malic acid, and tartaric acid are removed is used. Therefore, the highly pure compound (1) can be easily obtained.
  • the compound (1) produced in the present invention uses only water as a reaction solvent and a washing solvent used in the production process, methanol, ethanol, butanol, chloroform, methylene chloride, acetonitrile, Dimethylformamide, acetone, dimethyl Since organic solvents such as til sulfoxide are not used, there is no concern about residual solvents that are harmful to humans and animals.
  • This step is the same as step a in I above.
  • This process is the same as the process b in I above.
  • This step can be carried out by recrystallizing the precipitate after performing a filtration operation by a conventional method to obtain the precipitate.
  • the compound (2) can be produced by cooling and recrystallization.
  • the effective cooling temperature is usually in the range of 10 ° C to 30 ° C, preferably in the range of 5 ° C to 25 ° C, more preferably in the range of 0 ° C to 20 ° C.
  • the cooling time is suitably in the range of 1 minute to 48 hours, preferably in the range of 10 minutes to 36 hours, and more preferably in the range of 20 minutes to 24 hours.
  • the compound (2) that can be produced in this step has been difficult to completely remove until now, such as polysaccharides bectin, organic acids such as citrate, malic acid, tartaric acid, etc. Contain substantially no impurities.
  • the compound (2) produced in the present invention uses only water as the reaction solvent and washing solvent used in the production process, methanol, ethanol, butanol, chloroform, methylene chloride, acetonitrile, Since organic solvents such as dimethylformamide, acetone, and dimethyl sulfoxide are not used, there is no concern about residual solvents that are harmful to humans and animals.
  • Example 1 While stirring 30 mL of water in 20 g of Garcinia Extract (Garcitric Gold (registered trademark) Liquid; made in Renaissance Herbnet (USA); containing 60.75 wt% as HCA), 3.03 g, 3.46 g, 3. Add 89g, 4.33g or 4.76g of calcium hydroxide and 85. Each reaction solution stirred for 30 minutes at C was allowed to stand at 5 ° C for 2 days, and the resulting precipitate was collected by filtration. The results are shown in Table 1.
  • H PLCJ high performance liquid chromatography
  • HPLC system Liquid feed: LC-7A (manufactured by Shimadzu Corporation)
  • SPD 10AV (manufactured by Shimadzu Corporation)
  • UV-visible spectrometer detection wavelength 210nm
  • peak 1 represents impurities contained in the mobile phase
  • peak 2 represents HCA ratatones
  • peak 3 represents HCA
  • peak 4 represents the organic acid citrate.
  • Example 1 only the mobile phase used was analyzed by HPLC. Mouth matogram was obtained.
  • Example 2 As a result of HPLC analysis of the garcinia extract used in Example 1, a chromatogram as shown in FIG. 2 was obtained. It was confirmed that the garcinia extract contained at least citrate (a substance having a retention time of about 8 minutes) as an impurity.
  • Example 1 the results of using 0.9% molar ratio of calcium hydroxide to HCA contained in the Garcinia extract used in Fig. 5 are used in Example 1.
  • Fig. 6 shows the results when calcium hydroxide is used at a molar ratio of HCA contained in Garcinia extract.
  • Example 1,! / The precipitate obtained when using 0.9 times the molar ratio of calcium hydroxide and calcium hydroxide with respect to the HCA contained in the Garcinia extract used, It was confirmed that the impurity citrate (peak 4 in Figs. 5 and 6) was included.
  • Example 1 the result of using 0.7% molar ratio of calcium hydroxide with respect to HCA contained in the Garcinia extract used in FIG. 3 is used in Example 1.
  • Figure 4 shows the results of using 0.8 times the molar ratio of calcium hydroxide relative to the HCA contained in Garcinia extract.
  • Example 1! Precipitates obtained when calcium hydroxide with a molar ratio of 0.8 times or less with respect to HCA contained in the used Garcinia extract has been difficult to remove completely until now.
  • impurities such as polysaccharides such as bectine, organic acids such as citrate, malic acid and tartaric acid were not included.
  • Example 1 each precipitate obtained when 0.7 times and 0.8 times the molar ratio of calcium hydroxide was used with respect to the HCA contained in the Garcinia extract used in Example 1. 10 mL of water was added, dissolved by heating at 90 ° C, and then the precipitate obtained by standing was subjected to HPLC measurement and measurement of the amount of calcium contained in the precipitate. The amount of calcium contained in the precipitate was measured according to a known method using 0.05M ethylenediamine tetraacetic acid aqueous solution. It was confirmed that the recrystallized precipitates were only HCA rataton calcium salts (peak 2 in Figs. 7 and 8) (see Figs. 7 and 8).
  • the filtrate was allowed to stand overnight at 5 ° C, and 1.5 kg of the deposited precipitate (HCA rataton calcium salt) was collected by filtration.
  • the amount of calcium contained in the precipitate was measured according to a known method using 0.05 M ethylenediamine tetraacetic acid aqueous solution.
  • the obtained crude calcium salt of HCA was charged with 8.25 L of water, heated to 50 ° C. and stirred for 5 minutes, and then subjected to solid-liquid separation with a centrifuge for 10 minutes. The obtained solid was collected and the same purification operation was performed again. The obtained solid was dried at 100 ° C for 1 hour, and then the solid was pulverized, and then dried at 80 ° C for 41 hours and 115 ° C for 7 hours to obtain 0.62 kg of the target compound (yield: 53% ).
  • compound (1) Since no organic solvent is used in the production process of compound (1), compound (1) can be produced safely and at low cost, and there is no concern about residual organic solvent. In addition, since a precipitate from which impurities such as citrate, malic acid, tartaric acid, etc., which are organic acids, such as bectin, which is a polysaccharide contained in Garcinia extract, is removed, a high-purity compound ( 1) can be manufactured.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A novel process for producing alkaline earth metal salts of (-)-hydroxycitric acid (hereinafter referred to as “compounds (1)”)represented by the general structural formula: (1) wherein M is an alkaline earth metal. There is provided a process for producing compounds (1), comprising the steps of reacting with an extract of garcinia cambogia an alkaline earth metal oxide or alkaline earth metal hydroxide or hydroxide thereof amounting in molar ratio to 0.5 to less than 0.9 foldness of (-)-hydroxycitric acid contained in the garcinia cambogia, preferably followed by cooling, and collecting resultant deposit; and reacting the collected deposit with an alkaline earth metal salt and a base and separating the compounds (1).

Description

(一)—ヒドロキシクェン酸のアルカリ土類金属塩の製造法  (1) —Method for producing alkaline earth metal salt of hydroxyquenate
技術分野  Technical field
[0001] 本発明は、次の一般構造式(1)で表される(一)—ヒドロキシクェン酸 (以下、「HCA 」という。)のアルカリ土類金属塩 (以下、「化合物(1)」という。)又はその水和物の新 規な製造法に関するものである。  [0001] The present invention relates to an alkaline earth metal salt (hereinafter referred to as "compound (1)") represented by the following general structural formula (1): (1) -hydroxyquenic acid (hereinafter referred to as "HCA") Or a new method for producing the hydrate.
[化 1]
Figure imgf000002_0001
[Chemical 1]
Figure imgf000002_0001
[式中、 Mは、アルカリ土類金属を表す。 ] [Wherein M represents an alkaline earth metal. ]
背景技術  Background art
[0002] HCAは、例えば、ガルシニア(Garcinia)の果皮に多く含まれる物質として知られ、 クェン酸力 脂肪を合成する経路上の酵素の 1つである ATPクェン酸リア一ゼを阻 害し、体脂肪量の増加を抑制することから、肥満治療に有用であることが知られてい る (例えば、特許文献 1を参照。 ) o  [0002] For example, HCA is known as a substance abundant in the skin of Garcinia, and inhibits ATP citrate lyase, one of the enzymes on the pathway to synthesize citrate fat. It is known to be useful in the treatment of obesity because it suppresses the increase in fat mass (see, for example, Patent Document 1).
[0003] 一般に、 HCAは、 Lewis, Y. S.らの方法によりガルシニア(Garcinia)の果皮から 抽出して取得することができ、また、その塩は、 HCAから常法により取得することがで きる(例えば、非特許文献 1、非特許文献 2、特許文献 2を参照。;)。 HCA及びその塩 は、 Lewis, Y. S.らの方法のほか、例えば、特許文献 3, 4, 5, 6, 7の記載の方法 に準じて製造することができる。しかし、これらの方法では、例えば、不純物であるべ クチンや有機酸であるクェン酸、リンゴ酸、酒石酸等を全て除くことができず、高純度 の HCA等を製造することが困難である。  [0003] Generally, HCA can be obtained by extraction from the skin of Garcinia by the method of Lewis, YS, and the like, and its salt can be obtained from HCA by a conventional method (for example, , Non-Patent Document 1, Non-Patent Document 2, and Patent Document 2;). HCA and its salts can be produced according to the method described in Patent Documents 3, 4, 5, 6, 7 in addition to the method of Lewis, Y. S. et al. However, these methods cannot remove all impurities such as bectin and organic acids such as citrate, malic acid and tartaric acid, and it is difficult to produce high-purity HCA and the like.
特に、 HCAのカルシウム塩については、ガルシニアエキスに過剰量の水酸化カル シゥムを反応させることによって製造することができるが、同時に、水酸化カルシウム により該エキスに含まれるぺクチンが固いゲルを形成し、またクェン酸、マレイン酸が 水に難溶性のカルシウム塩を形成するので、高純度のものを取得することが公知の 製法では困難である。 In particular, the calcium salt of HCA can be produced by reacting an excess amount of calcium hydroxide with garcinia extract. At the same time, pectin contained in the extract forms a hard gel with calcium hydroxide. It is also known to obtain a high-purity substance because citrate and maleic acid form calcium salts that are sparingly soluble in water. It is difficult with the manufacturing method.
特許文献 1:米国特許第 3764692号公報  Patent Document 1: US Patent No. 3764692
特許文献 2 :インド特許第 160753号公報  Patent Document 2: Indian Patent No. 160753
特許文献 3:国際公開第 99Z03464号パンフレット  Patent Document 3: Pamphlet of International Publication No. 99Z03464
特許文献 4 :米国特許第 6875891公報  Patent Document 4: US Patent No. 6875891
特許文献 5:国際公開第 2004Z100682号パンフレット  Patent Document 5: International Publication No. 2004Z100682 Pamphlet
特許文献 6:米国特許第 6160172号公報  Patent Document 6: US Pat. No. 6,160,172
特許文献 7 :欧州特許第 866137号公報  Patent Document 7: European Patent No.866866
非特許文献 l : "Phytochemistry,,, 1965年, 4卷, p. 619— 625  Non-patent literature l: "Phytochemistry, 1965, 4 卷, p. 619—625
非特許文献 2 : Lewis, Y. S.ら, "Methods In Enzymology", 1969年, 13卷, p. 613 - 617  Non-Patent Document 2: Lewis, Y. S. et al., “Methods In Enzymology”, 1969, 13 卷, p. 613-617
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明の目的は、主として、高純度の化合物(1)を得るための新規な製造法を提 供することにある。 [0004] An object of the present invention is mainly to provide a novel production method for obtaining a highly pure compound (1).
ここで、「高純度」とは、 96%以上をいい、好ましくは 98%以上、さらに好ましくは 99 %以上である。  Here, “high purity” means 96% or more, preferably 98% or more, and more preferably 99% or more.
課題を解決するための手段  Means for solving the problem
[0005] 本発明者らは、鋭意研究を重ねた結果、上記目的を達成し得る製造法を見出し、 本発明を完成するに至った。また、幸いにも、化合物(1)の中間体である次の一般構 造式(2)で表される HCAのラタトン体のアルカリ土類金属塩 (以下、「化合物(2)」と いう。)又はその水和物を簡便に高純度で得る製造法も同時に見出した。 [0005] As a result of intensive studies, the present inventors have found a production method that can achieve the above object, and have completed the present invention. Fortunately, it is an alkaline earth metal salt (hereinafter referred to as “compound (2)”) of a rataton HCA represented by the following general structural formula (2), which is an intermediate of compound (1). Or a production method for easily obtaining the hydrate thereof with high purity.
[化 2]
Figure imgf000003_0001
[Chemical 2]
Figure imgf000003_0001
Mは、前記と同義である。 J [0006] 本発明として、例えば、下記工程 a〜eを少なくとも有する、化合物(1)又はその水 和物の製造法を挙げることができる。 M is as defined above. J [0006] Examples of the present invention include a method for producing compound (1) or a hydrate thereof having at least the following steps a to e.
工程 a :ガルシニアエキスと、ガルシニアに含まれる HCAに対してモル比で 0. 5倍以 上 0. 9倍未満の範囲内のアルカリ土類金属酸ィ匕物又はアルカリ土類金属水酸ィ匕物 若しくはその水和物とを反応させる工程、  Process a: Garcinia extract and alkaline earth metal hydroxide or alkaline earth metal hydroxide in a molar ratio of 0.5 to 0.9 times the HCA contained in Garcinia Reacting the product or its hydrate,
工程 b :工程 aの反応液を放置又は冷却することにより生成物を析出させる工程、 工程 c :析出物を取得する工程、  Step b: A step of depositing a product by leaving or cooling the reaction solution of Step a, Step c: A step of obtaining the precipitate,
工程 d :取得した析出物に、アルカリ土類金属塩又はその水和物と塩基とを反応させ る工程、  Step d: a step of reacting the obtained precipitate with an alkaline earth metal salt or hydrate thereof and a base,
工程 e:工程 dの反応の反応液カゝら HCAのアルカリ土類金属塩又はその水和物を取 得する工程。  Step e: A step of obtaining an alkaline earth metal salt of HCA or a hydrate thereof from the reaction solution in step d.
[0007] また、本発明として、下記工程 a'〜c 'を少なくとも有する、化合物(2)又はその水和 物の製造法を挙げることができる。  [0007] Further, the present invention can include a method for producing compound (2) or a hydrate thereof having at least the following steps a 'to c'.
工程 a,:ガルシニアエキスと、ガルシニアに含まれる HCAに対してモル比で 0. 5倍 以上 0. 9倍未満の範囲内のアルカリ土類金属酸ィ匕物又はアルカリ土類金属水酸ィ匕 物若しくはその水和物とを反応させる工程、  Step a ,: Alkaline earth metal oxide or alkaline earth metal hydroxide in a range of 0.5 times or more and less than 0.9 times in molar ratio to Garcinia extract and HCA contained in Garcinia Reacting the product or its hydrate,
工程 b':工程 a'の反応液を放置又は冷却することにより生成物を析出させる工程、 工程 c':析出物を取得し、さらに取得した析出物を再結晶化する工程。  Step b ′: a step of depositing a product by leaving or cooling the reaction liquid in step a ′, step c ′: a step of acquiring the precipitate and recrystallizing the acquired precipitate.
図面の簡単な説明  Brief Description of Drawings
[0008] [図 1]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  [0008] Fig. 1 shows a chromatogram obtained by HPLC analysis. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
[図 2]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  [Figure 2] Shows the chromatogram obtained by HPLC analysis. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
[図 3]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  [Fig. 3] Shows a chromatogram obtained by HPLC analysis. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
[図 4]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  [FIG. 4] A chromatogram obtained by HPLC analysis is shown. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
[図 5]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。 [FIG. 5] A chromatogram obtained by HPLC analysis is shown. In the figure, the vertical axis represents time (minutes) and horizontal The axis indicates the absorption intensity.
[図 6]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  [Fig. 6] A chromatogram obtained by HPLC analysis is shown. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
[図 7]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  FIG. 7 shows a chromatogram obtained by HPLC analysis. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
[図 8]HPLC分析により得られたクロマトグラムを表す。図中、縦軸は、時間(分)、横 軸は吸収強度を示す。  FIG. 8 shows a chromatogram obtained by HPLC analysis. In the figure, the vertical axis represents time (minutes) and the horizontal axis represents absorption intensity.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0009] 以下、本発明につ 、て詳述する。 Hereinafter, the present invention will be described in detail.
Lイ^^ (1) びその 7k禾 D )の 去  L Lee ^^ (1) and the end of 7k 禾 D)
(1)工程 aについて  (1) About process a
ガノレシニアエキスは、 HCAを多量に含むエキスであって、例えば、ゴラカ(Garcini a cambogia)、インドマンコスチン (Garcinia indica)、グルグル (Garcinia atro viridis)の果皮力 水やアルコール等で常法の抽出操作を行うことによって得ること ができる。  Ganorescinia extract is an extract that contains a large amount of HCA. It can be obtained by performing an extraction operation.
ガルシニアエキスには微量ではある力 例えば、ぺクチン等の多糖類、クェン酸、リ ンゴ酸、酒石酸等の有機酸を含んでいる。このような不純物が含まれているガルシ- ァェキスでも、本発明に使用することができる。  Garcinia extract contains a small amount of strength, for example, polysaccharides such as pectin, and organic acids such as citrate, lingoic acid and tartaric acid. Even a garshi layer containing such impurities can be used in the present invention.
現在、ガルシニアエキスは、 10重量%〜70重量%の範囲内の HCAを含有する水 溶液として巿販されている。このような巿販品として、例えば、ガルシニアエキス S (日 本新薬株式会社製)、 Garcitric Gold (登録商標)(ルネッサンスハーブ社製 (米国 )、 Citrin (登録商標)(サビンサ社製 (米国))、 Citrimax (登録商標)(インターヘル ス社製 (米国) )を挙げることができる。  Currently, Garcinia extract is marketed as an aqueous solution containing HCA in the range of 10% to 70% by weight. Examples of such commercial products include Garcinia Extract S (manufactured by Nippon Shinyaku Co., Ltd.), Garcitric Gold (registered trademark) (manufactured by Renaissance Herb (USA), Citrin (registered trademark) (manufactured by Sabinsa (USA)). Citrimax (registered trademark) (manufactured by Interhealth (USA)).
上記ガルシニアエキス中に含まれる HCAの濃度は、 5重量%〜90重量%の範囲 内が適当であり、好ましくは 7重量%〜80重量%の範囲内、さらに好ましくは 10重量 %〜70重量%の範囲内である。必要であれば、ガルシニアエキス中に含まれる HC Aの濃度を調整するため、水を添加してもよい。  The concentration of HCA contained in the garcinia extract is suitably within the range of 5% to 90% by weight, preferably within the range of 7% to 80% by weight, more preferably 10% to 70% by weight. Is within the range. If necessary, water may be added to adjust the concentration of HCA contained in the Garcinia extract.
[0010] ガルシニアエキスとアルカリ土類金属酸ィ匕物又はアルカリ土類金属水酸ィ匕物若しく はその水和物との反応は、例えば、ガルシニアエキスとアルカリ土類金属酸ィ匕物又 はアルカリ土類金属水酸ィ匕物若しくはその水和物とを水溶液中で、加熱攪拌するこ とにより行うことができる。その際、必要であれば、適当量の活性炭を添加してもよい。 「アルカリ土類金属酸ィ匕物」としては、例えば、酸ィ匕カルシウムを挙げることができる。 「アルカリ土類金属水酸ィ匕物又はその水和物」としては、例えば、水酸化カルシウム 又はその水和物を挙げることができる。この中で、特に、水酸化カルシウム二水和物 が好ましい。 [0010] Garcinia extract and alkaline earth metal hydroxide or alkaline earth metal hydroxide The reaction with the hydrate is carried out by, for example, stirring the garcinia extract and the alkaline earth metal oxide or alkaline earth metal hydroxide or hydrate in an aqueous solution while heating and stirring. Can be performed. At that time, if necessary, an appropriate amount of activated carbon may be added. Examples of the “alkaline earth metal oxides” include acid calcium. Examples of the “alkaline earth metal hydroxide or hydrate thereof” include calcium hydroxide or a hydrate thereof. Among these, calcium hydroxide dihydrate is particularly preferable.
[0011] アルカリ土類金属酸ィ匕物又はアルカリ土類金属水酸ィ匕物若しくはその水和物の使 用量は、反応液が塩基性を示さなければ、特に限定されないが、例えば、使用する ガルシニアエキスに含まれる HCAに対してモル比で 0. 5倍以上 0. 9倍未満の範囲 内が適当であり、好ましくは、 0. 7倍以上 0. 9倍未満の範囲内、さらに好ましくは 0. [0011] The amount of the alkaline earth metal oxide or alkaline earth metal hydroxide or hydrate thereof is not particularly limited as long as the reaction solution does not show basicity. The molar ratio with respect to HCA contained in the Garcinia extract is suitably in the range of 0.5 times or more and less than 0.9 times, preferably in the range of 0.7 times or more and less than 0.9 times, more preferably 0.
8倍以上 0. 9倍未満の範囲内である。 It is within the range of 8 times or more and less than 0.9 times.
[0012] 活性炭を使用する場合のその使用量は、使用するガルシニアエキスによって異な るが、ガルシニアエキスに含まれる HCAに対して 1重量%〜 10重量%の範囲内が 適当であり、好ましくは 2重量%〜7重量%の範囲内、さらに好ましくは 3重量%〜4 重量%の範囲内である。 [0012] The amount of activated carbon used varies depending on the garcinia extract used, but is suitably in the range of 1 to 10% by weight with respect to the HCA contained in the garcinia extract, preferably 2 It is in the range of 7% by weight to 7% by weight, more preferably in the range of 3% to 4% by weight.
[0013] 反応温度は、ガルシニアエキス中に含まれる HCAの濃度、及びアルカリ土類金属 酸ィ匕物又はアルカリ土類金属水酸ィ匕物の使用量によって異なる力 通常 20°C〜10[0013] The reaction temperature varies depending on the concentration of HCA contained in the Garcinia extract and the amount of alkaline earth metal oxide or alkaline earth metal hydroxide used. Usually 20 ° C to 10 ° C
0°Cの範囲内が適当であり、好ましくは 40°C〜95°Cの範囲内、さらに好ましくは 60°CThe range of 0 ° C is suitable, preferably within the range of 40 ° C to 95 ° C, more preferably 60 ° C.
〜90°Cの範囲内である。 Within the range of ~ 90 ° C.
反応時間は、反応温度等によって異なるが、 1分〜 24時間の範囲内が適当であり Although the reaction time varies depending on the reaction temperature, etc., it is suitable within the range of 1 minute to 24 hours.
、好ましくは 5分〜 12時間の範囲内、さらに好ましくは 10分〜 1時間の範囲内である , Preferably within the range of 5 minutes to 12 hours, more preferably within the range of 10 minutes to 1 hour.
[0014] (2)工程 bについて [0014] (2) About step b
本工程は、工程 aの反応終了後、工程 aの反応液を、例えば、そのまま常温で放置 することによって実施することができる。また、工程 aの反応液を冷却することによって も実施することができ、常温で放置するよりも冷却する方が好ましい。力かる冷却温度 としては、通常— 10°C〜30°Cの範囲内が適当であり、好ましくは— 5°C〜25°Cの範 囲内、さらに好ましくは 0°C〜20°Cの範囲内である。冷却時間は、 1分〜 48時間の範 囲内が適当であり、好ましくは 10分〜 36時間の範囲内、さらに好ましくは 20分〜 24 時間の範囲内である。 This step can be performed, for example, by leaving the reaction solution of step a as it is at room temperature after completion of the reaction of step a. It can also be carried out by cooling the reaction solution in step a, and it is preferable to cool it rather than leaving it at room temperature. The effective cooling temperature is usually in the range of 10 ° C to 30 ° C, preferably in the range of 5 ° C to 25 ° C. Within the range, more preferably within the range of 0 ° C to 20 ° C. The cooling time is suitably in the range of 1 minute to 48 hours, preferably in the range of 10 minutes to 36 hours, and more preferably in the range of 20 minutes to 24 hours.
[0015] (3)工程 cについて [0015] (3) About step c
本工程は、常法により濾過操作を行うことによって実施することができる。 本工程 cにおいて製造することができる析出物は、これまで完全に取り除くことが困 難であった、多糖類であるべクチン等、有機酸であるクェン酸、リンゴ酸、酒石酸等の 不純物を実質的に含有して 、な 、。  This step can be performed by performing a filtration operation by a conventional method. The precipitates that can be produced in this step c are substantially free of impurities such as bectin, which is a polysaccharide, citrate, malic acid, tartaric acid, which are organic acids, which have been difficult to remove completely until now. Contained in a way.
[0016] (4)工程 dについて [0016] (4) Step d
本工程は、例えば、工程 cで取得した析出物を水に加熱溶解し、アルカリ土類金属 塩又はその水和物と塩基とを加えて、加熱攪拌することにより実施することができる。 必要に応じて、アルカリ土類金属塩を添加した後に、濾過操作を行うことができる。  This step can be carried out, for example, by dissolving the precipitate obtained in step c with heating in water, adding an alkaline earth metal salt or hydrate thereof and a base, and stirring with heating. If necessary, a filtering operation can be performed after adding the alkaline earth metal salt.
[0017] 水の使用量は、例えば、析出物に対して重量比で 5倍〜 100倍の範囲内が適当で あり、好ましくは 10倍〜 70倍の範囲内、さらに好ましくは 20倍〜 40倍の範囲内であ る。 [0017] The amount of water used is, for example, suitably in the range of 5 to 100 times by weight with respect to the precipitate, preferably in the range of 10 to 70 times, more preferably 20 to 40 times. Within double range.
アルカリ土類金属塩としては、例えば、カルシウム塩を挙げることができる。 「カルシウム塩」としては、例えば、塩ィ匕カルシウム、硫酸カルシウム、炭酸カルシゥ ム若しくは臭化カルシウムを挙げることができる。この中で、塩ィ匕カルシウム二水和物 が特に好ましい。  Examples of alkaline earth metal salts include calcium salts. Examples of the “calcium salt” include calcium chloride, calcium sulfate, calcium carbonate, and calcium bromide. Of these, calcium chloride dihydrate is particularly preferred.
アルカリ土類金属塩又はその水和物の使用量としては、例えば、析出物に対してモ ル比で 0. 40倍〜 0. 70倍の範囲内が適当であり、好ましくは 0. 45倍〜 0. 65倍の 範囲内、さらに好ましくは 0. 50倍〜 0. 60倍の範囲内である。  The amount of the alkaline earth metal salt or hydrate thereof used is, for example, suitably in the range of 0.40 times to 0.70 times, preferably 0.45 times the molar ratio to the precipitate. Within the range of ~ 0.65 times, more preferably within the range of 0.50 times to 0.660 times.
「塩基」としては、アンモニア水、ピリジン、トリメチルァミン等のアミン類を挙げること ができる。  Examples of the “base” include amines such as aqueous ammonia, pyridine, and trimethylamine.
塩基の使用量としては、例えば、析出物に対してモル比で 0. 5倍〜 2. 0倍の範囲 内が適当であり、好ましくは、 0. 9倍〜 1. 5倍の範囲内、さらに好ましくは 1. 0倍〜 1 . 2倍の範囲内である。  The amount of base used is, for example, suitably in the range of 0.5 to 2.0 times in molar ratio to the precipitate, preferably in the range of 0.9 to 1.5 times, More preferably, it is in the range of 1.0 times to 1.2 times.
反応温度としては、通常 20°C〜100°Cの範囲内が適当であり、好ましくは 30°C〜9 5°Cの範囲内、さらに好ましくは 40°C〜90°Cの範囲内である。 The reaction temperature is usually within the range of 20 ° C to 100 ° C, preferably 30 ° C to 9 ° C. It is within the range of 5 ° C, more preferably within the range of 40 ° C to 90 ° C.
反応時間は、反応温度等によって異なるが、 1分〜 12時間の範囲内が適当であり 、好ましくは 5分〜 7時間の範囲内、さらに好ましくは 10分〜 2時間の範囲内である。  The reaction time varies depending on the reaction temperature and the like, but is suitably in the range of 1 minute to 12 hours, preferably in the range of 5 minutes to 7 hours, and more preferably in the range of 10 minutes to 2 hours.
[0018] (5)工程 eについて [0018] (5) Process e
工程 dの反応液中の化合物(1)は、公知の固液分離操作を行うことにより、化合物( 1)を取得することができる。固液分離操作を行う際、水を使用して化合物(1)を洗浄 することができる。固液分離操作としては、例えば、濾過操作、遠心分離機又は搾汁 機による脱水操作を挙げることができる。  The compound (1) in the reaction liquid in the step d can be obtained by performing a known solid-liquid separation operation. When performing the solid-liquid separation operation, the compound (1) can be washed with water. Examples of the solid-liquid separation operation include a filtration operation, a dehydration operation using a centrifuge, or a juicer.
また、必要に応じて、化合物(1)はさらに精製操作を行うことができる。具体的には 、例えば、取得した化合物(1)に対して重量比で 10倍〜 20倍の水をカ卩ぇ攪拌し、上 記固液分離操作を行うことによって、さらに純度を高めることができる。必要であれば 、 40°C〜60°Cの範囲内で加熱攪拌してもよい。  If necessary, the compound (1) can be further purified. Specifically, the purity can be further increased by, for example, stirring the water of 10 to 20 times by weight with respect to the obtained compound (1) and performing the above solid-liquid separation operation. it can. If necessary, the mixture may be heated and stirred within a range of 40 ° C to 60 ° C.
[0019] 固液分離操作を行うことによって得られた化合物(1)は、大量の水を含有している ので、乾燥操作を行うことが好ましい。 [0019] Since the compound (1) obtained by performing the solid-liquid separation operation contains a large amount of water, it is preferable to perform a drying operation.
乾燥操作としては、例えば、減圧下における乾燥を挙げることができる。 減圧力としては、例えば、 1. 0xl0_13Pa〜l. 0xl05Paの範囲内が適当であり、好 ましくは 1. 0xl0_9Pa〜l. 0xl04Paの範囲内、さらに好ましくは 1. 0xl0"5Pa~l. 0xl03Paの範囲内である。 Examples of the drying operation include drying under reduced pressure. The vacuum force, for example, 1. 0xl0 _13 Pa~l. 0xl0 5 Pa and is suitably within the range of, the good Mashiku 1. 0xl0 _9 Pa~l. 0xl0 4 within the Pa, more preferably 1. 0xl0 " 5 Pa ~ l. Within the range of 0xl0 3 Pa.
乾燥温度は、例えば、 50°C〜140°Cの範囲内が適当であり、好ましくは 60°C〜13 0°Cの範囲内、さらに好ましくは 70°C〜120°Cの範囲内である。  The drying temperature is, for example, suitably in the range of 50 ° C to 140 ° C, preferably in the range of 60 ° C to 130 ° C, more preferably in the range of 70 ° C to 120 ° C. .
乾燥時間は、 1時間〜 96時間の範囲内が適当であり、好ましくは 12時間〜 72時間 の範囲内、さらに好ましくは 24時間〜 48時間の範囲内である。  The drying time is suitably in the range of 1 hour to 96 hours, preferably in the range of 12 hours to 72 hours, more preferably in the range of 24 hours to 48 hours.
[0020] 化合物(1)の製造には、多糖類であるべクチン等、有機酸であるクェン酸、リンゴ酸 、酒石酸等の不純物が取り除かれた、工程 cで製造される析出物を使用するので、容 易に高純度の化合物(1)を取得することができる。 [0020] For the production of compound (1), the precipitate produced in step c from which impurities such as bectin, a polysaccharide, and organic acids such as citrate, malic acid, and tartaric acid are removed is used. Therefore, the highly pure compound (1) can be easily obtained.
また、本発明において製造される化合物(1)は、その製造工程において使用する 反応溶媒及び洗浄溶媒としては、水のみを使用し、メタノール、エタノール、ブタノー ル、クロ口ホルム、塩化メチレン、ァセトニトリル、ジメチルホルムアミド、アセトン、ジメ チルスルホキシドなどの有機溶媒を使用しな 、ので、人や動物に有害な残留溶媒の 心配がない。 Further, the compound (1) produced in the present invention uses only water as a reaction solvent and a washing solvent used in the production process, methanol, ethanol, butanol, chloroform, methylene chloride, acetonitrile, Dimethylformamide, acetone, dimethyl Since organic solvents such as til sulfoxide are not used, there is no concern about residual solvents that are harmful to humans and animals.
[0021] II.化合物(2)及びその水和物の製法  [0021] II. Method for producing compound (2) and hydrates thereof
(1)工程 a'について  (1) About process a '
本工程は、前述 Iの工程 aと同じである。  This step is the same as step a in I above.
(2)工程 b,について  (2) About step b
本工程は、前述 Iの工程 bと同じである。  This process is the same as the process b in I above.
(3)工程 c'について  (3) About process c '
本工程は、常法により濾過操作を行い析出物を取得した後、該析出物を再結晶化 すること〖こより実施することができる。  This step can be carried out by recrystallizing the precipitate after performing a filtration operation by a conventional method to obtain the precipitate.
取得した析出物に対して、例えば、重量比で等倍〜 10倍の範囲内の水を加え、 50 °C〜100°Cの範囲内に加熱し析出物を溶解し、そのまま常温で放置又は冷却して再 結晶化することにより、化合物(2)を製造することができる。力かる冷却温度としては、 通常— 10°C〜30°Cの範囲内が適当であり、好ましくは— 5°C〜25°Cの範囲内、さら に好ましくは 0°C〜20°Cの範囲内である。冷却時間は、 1分〜 48時間の範囲内が適 当であり、好ましくは 10分〜 36時間の範囲内、さらに好ましくは 20分〜 24時間の範 囲内である。  To the obtained precipitate, for example, water in the range of 1 to 10 times by weight is added and heated in the range of 50 ° C to 100 ° C to dissolve the precipitate and left as it is at room temperature or The compound (2) can be produced by cooling and recrystallization. The effective cooling temperature is usually in the range of 10 ° C to 30 ° C, preferably in the range of 5 ° C to 25 ° C, more preferably in the range of 0 ° C to 20 ° C. Within range. The cooling time is suitably in the range of 1 minute to 48 hours, preferably in the range of 10 minutes to 36 hours, and more preferably in the range of 20 minutes to 24 hours.
[0022] 本工程において製造することができる化合物(2)は、これまで完全に取り除くことが 困難であった、多糖類であるべクチン等、有機酸であるクェン酸、リンゴ酸、酒石酸等 の不純物を実質的に含有して 、な 、。  [0022] The compound (2) that can be produced in this step has been difficult to completely remove until now, such as polysaccharides bectin, organic acids such as citrate, malic acid, tartaric acid, etc. Contain substantially no impurities.
また、本発明において製造される化合物(2)は、その製造工程において使用する 反応溶媒及び洗浄溶媒としては、水のみを使用し、メタノール、エタノール、ブタノー ル、クロ口ホルム、塩化メチレン、ァセトニトリル、ジメチルホルムアミド、アセトン、ジメ チルスルホキシドなどの有機溶媒を使用しな 、ので、人や動物に有害な残留溶媒の 心配がない。  In addition, the compound (2) produced in the present invention uses only water as the reaction solvent and washing solvent used in the production process, methanol, ethanol, butanol, chloroform, methylene chloride, acetonitrile, Since organic solvents such as dimethylformamide, acetone, and dimethyl sulfoxide are not used, there is no concern about residual solvents that are harmful to humans and animals.
[0023] 以下に、実施例を掲げて本発明を更に詳しく説明するが、本発明はこれらに限定さ れるものではない。  [0023] Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.
[0024] 実施例 1 20gのガルシニアエキス (Garcitric Gold (登録商標) Liquid;ルネッサンスハー ブネ土製(米国); HCAとして、 60. 75重量%含有)に水 30mLをカ卩ぇ攪拌しながら、 3 . 03g、 3. 46g、 3. 89g、 4. 33g又は 4. 76gの水酸ィ匕カルシウムを加え、 85。Cで 3 0分間攪拌したそれぞれの反応液を 2日間 5°Cで放置し、生じた析出物を濾取した。 その結果を表 1に示す。 [0024] Example 1 While stirring 30 mL of water in 20 g of Garcinia Extract (Garcitric Gold (registered trademark) Liquid; made in Renaissance Herbnet (USA); containing 60.75 wt% as HCA), 3.03 g, 3.46 g, 3. Add 89g, 4.33g or 4.76g of calcium hydroxide and 85. Each reaction solution stirred for 30 minutes at C was allowed to stand at 5 ° C for 2 days, and the resulting precipitate was collected by filtration. The results are shown in Table 1.
[表 1]
Figure imgf000010_0001
[table 1]
Figure imgf000010_0001
各条件において析出する析出物の純度は、高速液体クロマトグラフィー(以下、「H PLCJという。)装置を使用して確認した。  The purity of the precipitate deposited under each condition was confirmed using a high performance liquid chromatography (hereinafter referred to as “H PLCJ”) apparatus.
各条件において析出する析出物 0. lgを、全量が lOOmLとなるように水で希釈し、 下記条件で HPLC測定をした。  0.1 g of the precipitate precipitated under each condition was diluted with water so that the total amount became lOOmL, and HPLC measurement was performed under the following conditions.
[測定条件] [Measurement condition]
HPLC装置:送液ュ-ット: LC— 7A (島津製作所社製)  HPLC system: Liquid feed: LC-7A (manufactured by Shimadzu Corporation)
検出器: SPD— 10AV (島津製作所社製)  Detector: SPD—10AV (manufactured by Shimadzu Corporation)
有機酸分析用カラム: ULTRON PS-80H  Organic acid analysis column: ULTRON PS-80H
< 8mm φ x30cm〉 1本 (信和化工株式会社製)  <8mm φ x30cm> 1 (made by Shinwa Kako Co., Ltd.)
< 8mm φ x5cm> 1本 (信和化工株式会社製)  <8mm φ x5cm> 1 piece (Shinwa Kako Co., Ltd.)
カラム温度: 50°C Column temperature: 50 ° C
移動相:水 (過塩素酸を使用して pH 2. 20に調整) Mobile phase: water (adjusted to pH 2. 20 using perchloric acid)
流量: 0. 81mlZ分 Flow rate: 0.81mlZ min
紫外線可視分光器検出波長: 210nm UV-visible spectrometer detection wavelength: 210nm
注入量: 20 μ 1 Injection volume: 20 μ 1
結果を図 1〜8に示す。  The results are shown in Figs.
図 1〜8中、ピーク 1は移動相中に含まれる不純物を、ピーク 2は HCAのラタトン体 を、ピーク 3は HCAを、ピーク 4は有機酸のクェン酸を示す。  In FIGS. 1 to 8, peak 1 represents impurities contained in the mobile phase, peak 2 represents HCA ratatones, peak 3 represents HCA, and peak 4 represents the organic acid citrate.
実施例 1にお 、て使用した移動相のみを HPLC分析した結果、図 1に示すようなク 口マトグラムを得た。 In Example 1, only the mobile phase used was analyzed by HPLC. Mouth matogram was obtained.
実施例 1にお 、て使用したガルシニアエキスを HPLC分析した結果、図 2に示すよ うなクロマトグラムを得た。該ガルシニアエキスには、少なくともクェン酸 (保持時間が 約 8分である物質)が不純物として含まれて ヽることを確認した。  As a result of HPLC analysis of the garcinia extract used in Example 1, a chromatogram as shown in FIG. 2 was obtained. It was confirmed that the garcinia extract contained at least citrate (a substance having a retention time of about 8 minutes) as an impurity.
実施例 1にお 、て使用したガルシニアエキスに含まれる HCAに対してモル比で 0. 9倍の水酸ィ匕カルシウムを使用した場合の結果を図 5に、実施例 1にお 、て使用した ガルシニアエキスに含まれる HCAに対してモル比で等倍の水酸化カルシウムを使用 した場合の結果を図 6に示す。実施例 1にお!/、て使用したガルシニアエキスに含まれ る HCAに対してモル比で 0. 9倍、等倍の水酸ィ匕カルシウムを使用した場合に取得さ れる析出物には、不純物であるクェン酸(図 5, 6中のピーク 4)が含まれていることを 確認した。  In Example 1, the results of using 0.9% molar ratio of calcium hydroxide to HCA contained in the Garcinia extract used in Fig. 5 are used in Example 1. Fig. 6 shows the results when calcium hydroxide is used at a molar ratio of HCA contained in Garcinia extract. In Example 1,! /, The precipitate obtained when using 0.9 times the molar ratio of calcium hydroxide and calcium hydroxide with respect to the HCA contained in the Garcinia extract used, It was confirmed that the impurity citrate (peak 4 in Figs. 5 and 6) was included.
実施例 1にお 、て使用したガルシニアエキスに含まれる HCAに対してモル比で 0. 7倍の水酸ィ匕カルシウムを使用した場合の結果を図 3に、実施例 1にお 、て使用した ガルシニアエキスに含まれる HCAに対してモル比で 0. 8倍の水酸化カルシウムを使 用した場合の結果を図 4に示す。実施例 1にお!/、て使用したガルシニアエキスに含ま れる HCAに対してモル比で 0. 8倍以下の水酸ィ匕カルシウムを使用した場合に取得 される析出物には、これまで完全に取り除くことが困難であった、多糖類であるべクチ ン等、有機酸であるクェン酸、リンゴ酸、酒石酸等の不純物が含まれていないことを 確認した。  In Example 1, the result of using 0.7% molar ratio of calcium hydroxide with respect to HCA contained in the Garcinia extract used in FIG. 3 is used in Example 1. Figure 4 shows the results of using 0.8 times the molar ratio of calcium hydroxide relative to the HCA contained in Garcinia extract. In Example 1! / Precipitates obtained when calcium hydroxide with a molar ratio of 0.8 times or less with respect to HCA contained in the used Garcinia extract has been difficult to remove completely until now. It was also confirmed that impurities such as polysaccharides such as bectine, organic acids such as citrate, malic acid and tartaric acid were not included.
さらに実施例 1にお 、て使用したガルシニアエキスに含まれる HCAに対してモル 比で 0. 7倍、 0. 8倍の水酸ィ匕カルシウムを使用した場合に得られたそれぞれの析出 物に 10mLの水をカ卩え、 90°Cで加熱溶解した後、放置して得られた析出物について HPLC測定と析出物中に含まれるカルシウム量の測定を行った。析出物中に含まれ るカルシウム量は、 0. 05Mのエチレンジァミン四酢酸水溶液を使用する公知の方法 に従って測定した。再結晶化したそれぞれの析出物は、 HCAのラタトン体のカルシ ゥム塩(図 7, 8中のピーク 2)のみであることを確認した(図 7、 8参照)。  Further, in Example 1, each precipitate obtained when 0.7 times and 0.8 times the molar ratio of calcium hydroxide was used with respect to the HCA contained in the Garcinia extract used in Example 1. 10 mL of water was added, dissolved by heating at 90 ° C, and then the precipitate obtained by standing was subjected to HPLC measurement and measurement of the amount of calcium contained in the precipitate. The amount of calcium contained in the precipitate was measured according to a known method using 0.05M ethylenediamine tetraacetic acid aqueous solution. It was confirmed that the recrystallized precipitates were only HCA rataton calcium salts (peak 2 in Figs. 7 and 8) (see Figs. 7 and 8).
実施例 2 Example 2
4kgのガルシニアエキス(Garcitric Gold (登録商標) Liquid ;ルネッサンスハーブ 社製 (米国); HCAとして、 64. 0重量%含有)に 6Lの水をカ卩ぇ攪拌しながら、 0. 64 kgの水酸化カルシウム(8. 64mol;HCAに対してモル比で 0. 70倍の水酸化カルシ ゥム)と 100gの活性炭を加え、 85°Cで 30分間攪拌した。その後、反応混合物を 80 °Cの熱水で洗浄しながら濾過した。 4kg Garcinia Extract (Garcitric Gold (registered trademark) Liquid; Renaissance herb Co. (USA); HCA containing 64.0% by weight) While stirring 6L of water, 0.664 kg of calcium hydroxide (8.64 mol; molar ratio to HCA is 0. 70 times calcium hydroxide) and 100 g activated carbon were added and stirred at 85 ° C for 30 minutes. The reaction mixture was then filtered while washing with hot water at 80 ° C.
濾液を一晩 5°Cで放置し、析出した析出物 (HCAのラタトン体のカルシウム塩)を 1 . 5kg濾取した。  The filtrate was allowed to stand overnight at 5 ° C, and 1.5 kg of the deposited precipitate (HCA rataton calcium salt) was collected by filtration.
得られた HCAのラタトン体のカルシウム塩に 7. 7Lの水をカ卩え、 90°Cに加熱溶解し 、そのまま 5分間攪拌した後、濾過した。得られた濾液を再度 85°Cに加熱した後、 20 °C以下に冷却し、 30分間放置した後、生じた析出物を濾取して精製された HCAの ラタトン体のカルシウム塩を 1. 0kg得た(収率:51%)。  7.7 L of water was added to the calcium salt of the resulting HCA rataton body, dissolved by heating at 90 ° C., stirred as it was for 5 minutes, and then filtered. The obtained filtrate was heated again to 85 ° C, cooled to 20 ° C or lower, and allowed to stand for 30 minutes.The resulting precipitate was collected by filtration, and purified HCA ratatotone calcium salt 1. 0 kg was obtained (yield: 51%).
析出物中に含まれるカルシウム量は、 0. 05Mのエチレンジァミン四酢酸水溶液を 使用する公知の方法に従って測定した。  The amount of calcium contained in the precipitate was measured according to a known method using 0.05 M ethylenediamine tetraacetic acid aqueous solution.
融点: 250°C以上 Melting point: 250 ° C or higher
元素分析値(C H O Ca-4H Oとして) Elemental analysis value (as C H O Ca-4H O)
6 4 7 2  6 4 7 2
理論値: H:4. 03%, C: 24. 0%  Theoretical values: H: 4.0.3%, C: 24. 0%
実測値: H: 3. 88%, C: 23. 9%  Actual value: H: 3. 88%, C: 23.9%
カルシウム含量: Calcium content:
理論値: Ca: 13. 35% Theoretical value: Ca: 13. 35%
実測値: Ca: 13. 40% Actual value: Ca: 13. 40%
比旋光度: [ α ] 2°= 67. 0° (c = 0. 2, H O) Specific rotation: [α] 2 ° = 67. 0 ° (c = 0. 2, HO)
D 2  D 2
'Η NMR (D O)  'Η NMR (D O)
2  2
4. 84 (s, 1H) , 3. 18 (d, 1H) , 2. 83 (d, 1H)  4.84 (s, 1H), 3.18 (d, 1H), 2.83 (d, 1H)
実施例 3 HCAのカルシウム塩の製造 Example 3 Production of calcium salt of HCA
実施例 2で得られた 1. 0kg (4. 4mol)の HCAのラタトン体のカルシウム塩に 20L の水をカ卩え、 80°Cで 5分間加熱攪拌した。その後、 0. 35kgの塩ィ匕カルシウム二水 和物(2. 4mol)と 0. 5Lの水を加え、溶解した後、反応溶液を濾過した。得られた濾 液を再度 80°Cに加熱し、そのまま 5分間攪拌した後、 50°C〜60°Cに冷却した。反応 溶液に 0. 29kgの 28%アンモニア水を滴下し、 85°Cで 60分間攪拌した後、生じた 析出物を遠心分離機 (佐久間製作所製)で 10分間固液分離操作を行った。得られ た固体を集めて、粗製の HCAのカルシウム塩を 0.55kg得た。 20 L of water was added to 1.0 kg (4.4 mol) of HCA ratatotone calcium salt obtained in Example 2 and stirred at 80 ° C. for 5 minutes. Then, 0.35 kg of salty calcium dihydrate (2.4 mol) and 0.5 L of water were added and dissolved, and then the reaction solution was filtered. The obtained filtrate was heated again to 80 ° C., stirred as it was for 5 minutes, and then cooled to 50 ° C. to 60 ° C. 0.29 kg of 28% aqueous ammonia was added dropwise to the reaction solution and stirred at 85 ° C for 60 minutes. The precipitate was subjected to solid-liquid separation with a centrifuge (manufactured by Sakuma Seisakusho) for 10 minutes. The obtained solid was collected to obtain 0.55 kg of crude HCA calcium salt.
得られた粗製の HCAのカルシウム塩に 8.25Lの水をカ卩え、 50°Cに加熱し 5分間 攪拌した後、遠心分離機で 10分間固液分離操作を行った。得られた固体を集め、も う一度同様の精製操作を行った。得られた固体を 100°Cで 1時間乾燥した後、固体 を粉砕し、次いで 80°Cで 41時間、 115°Cで 7時間乾燥し、目的化合物を 0.62kg得 た (収率: 53%)。  The obtained crude calcium salt of HCA was charged with 8.25 L of water, heated to 50 ° C. and stirred for 5 minutes, and then subjected to solid-liquid separation with a centrifuge for 10 minutes. The obtained solid was collected and the same purification operation was performed again. The obtained solid was dried at 100 ° C for 1 hour, and then the solid was pulverized, and then dried at 80 ° C for 41 hours and 115 ° C for 7 hours to obtain 0.62 kg of the target compound (yield: 53% ).
融点: 250°C以上 Melting point: 250 ° C or higher
元素分析値(C H O Ca '5H Oとして) Elemental analysis value (as C H O Ca '5H O)
12 10 16 3 2  12 10 16 3 2
理論値: H:3.25%, C:23.23%  Theoretical values: H: 3.25%, C: 23.23%
実測値: H:3.40%, C:23.11%  Actual value: H: 3.40%, C: 23.11%
カルシウム含量: Calcium content:
理論値: Ca:19.38% Theoretical value: Ca: 19.38%
実測値: Ca:19.60% Actual value: Ca: 19.60%
比旋光度:[α] 2G=— 26.0° (c = 0.2, H O) Specific rotation: [α] 2G = — 26.0 ° (c = 0.2, HO)
D 2  D 2
'Η NMR(D O)  'Η NMR (D O)
2  2
4. ll(s, 2H), 2.84 (d, 2H), 2.64 (d, 2H)  4.ll (s, 2H), 2.84 (d, 2H), 2.64 (d, 2H)
産業上の利用可能性 Industrial applicability
化合物(1)の製造過程においては、有機溶媒を使用しないので、化合物(1)を安 全にかつ低コストで製造することができ、また残留有機溶媒の心配がない。また、一 且、ガルシニアエキスに含まれている多糖類であるべクチン等、有機酸であるクェン 酸、リンゴ酸、酒石酸等の不純物を除去した析出物を取得するので、高純度の化合 物(1)を製造することができる。  Since no organic solvent is used in the production process of compound (1), compound (1) can be produced safely and at low cost, and there is no concern about residual organic solvent. In addition, since a precipitate from which impurities such as citrate, malic acid, tartaric acid, etc., which are organic acids, such as bectin, which is a polysaccharide contained in Garcinia extract, is removed, a high-purity compound ( 1) can be manufactured.

Claims

請求の範囲 下記工程 a〜eを少なくとも有する、次の一般構造式(1)で表される( クェン酸のアルカリ土類金属塩又はその水和物の製造法。 Claims Represented by the following general structural formula (1) having at least the following steps a to e (a method for producing an alkaline earth metal salt of citrate or a hydrate thereof.
[化 1]
Figure imgf000014_0001
[Chemical 1]
Figure imgf000014_0001
[式中、 Mは、アルカリ土類金属を表す。 ] [Wherein M represents an alkaline earth metal. ]
工程 a :ガルシニアエキスと、ガルシニアエキスに含まれる(一)ーヒドロキシクェン酸に 対してモル比で 0. 5倍以上 0. 9倍未満の範囲内のアルカリ土類金属酸化物又はァ ルカリ土類金属水酸ィ匕物若しくはその水和物とを反応させる工程、  Process a: Garcinia extract and (1) Alkaline earth metal oxide or alkali earth within a molar ratio of 0.5 times or more and less than 0.9 times the molar ratio of hydroxycienic acid contained in Garcinia extract Reacting with metal hydroxide or its hydrate,
工程 b :工程 aの反応液を放置又は冷却することにより生成物を析出させる工程、 工程 c :析出物を取得する工程、  Step b: A step of depositing a product by leaving or cooling the reaction solution of Step a, Step c: A step of obtaining the precipitate,
工程 d :取得した析出物に、アルカリ土類金属塩又はその水和物と塩基とを反応させ る工程、  Step d: a step of reacting the obtained precipitate with an alkaline earth metal salt or hydrate thereof and a base,
工程 e:工程 dの反応の反応液から(一)—ヒドロキシクェン酸のアルカリ土類金属塩 又はその水和物を取得する工程。  Step e: A step of obtaining (1) -alkaline earth metal salt of hydroxy quenoic acid or a hydrate thereof from the reaction solution of the reaction of Step d.
[2] ガノレシニアエキスが、ゴラカ(Garcinia cambogia)、インドマンゴスチン(Garcinia indica)又はグルグル (Garcinia atroviridis)の果皮から抽出して得られるもので ある、請求項 1記載の(一)ーヒドロキシクェン酸のアルカリ土類金属塩又はその水和 物の製造法。 [2] (1) -Hydroxycene according to claim 1, wherein the ganoressin extract is obtained by extracting from the skin of goraka (Garcinia cambogia), indomangosteen (Garcinia inrovica) or garguru (Garcinia atroviridis). A method for producing an alkaline earth metal salt of an acid or a hydrate thereof.
[3] 工程 dで使用する塩基がアンモニア水、ピリジン又はトリメチルァミンである、請求項 1 又は 2のいずれかに記載の(一)ーヒドロキシクェン酸のアルカリ土類金属塩又はその 水和物の製造法。  [3] The alkaline earth metal salt of (1) -hydroxycenoic acid or a hydrate thereof according to any one of claims 1 and 2, wherein the base used in step d is ammonia water, pyridine or trimethylamine. Manufacturing method.
[4] 工程 aで使用するアルカリ土類金属酸ィ匕物が酸ィ匕カルシウムである、請求項 1〜3の いずれかに記載の(一)ーヒドロキシクェン酸のアルカリ土類金属塩又はその水和物 の製造法。  [4] The alkaline earth metal salt of (1) -hydroxyquenic acid according to any one of claims 1 to 3, wherein the alkaline earth metal oxide used in step a is calcium carbonate Hydrate manufacturing method.
工程 aで使用するアルカリ土類金属水酸ィ匕物又はその水和物が水酸ィ匕カルシウム又 はその水和物である、請求項 1〜3のいずれかに記載の(一)ーヒドロキシクェン酸の アルカリ土類金属塩又はその水和物の製造法。 The alkaline earth metal hydroxide or hydrate used in step a is a calcium hydroxide or calcium hydrate. 4. The method for producing an alkaline earth metal salt of (1) -hydroxyquenic acid or a hydrate thereof according to any one of claims 1 to 3, wherein is a hydrate thereof.
[6] 工程 dで使用するアルカリ土類金属塩又はその水和物がカルシウム塩又はその水和 物である、請求項 1〜5のいずれかに記載の(一)ーヒドロキシクェン酸のアルカリ土 類金属塩又はその水和物の製造法。  6. The alkaline earth metal salt of (1) -hydroxyquenic acid according to any one of claims 1 to 5, wherein the alkaline earth metal salt or hydrate thereof used in step d is a calcium salt or a hydrate thereof. For producing a metal salt or a hydrate thereof.
[7] カルシウム塩が塩化カルシウムである、請求項 6記載の(一)ーヒドロキシクェン酸の アルカリ土類金属塩又はその水和物の製造法。  7. The process for producing an alkaline earth metal salt of (1) -hydroxyquenoic acid or a hydrate thereof according to claim 6, wherein the calcium salt is calcium chloride.
[8] 下記工程 a'〜c 'を少なくとも有する、次の一般構造式 (2)で表される(一)ーヒドロキ シクェン酸のラタトン体のアルカリ土類金属塩又はその水和物の製造法。 [8] A process for producing an alkaline earth metal salt of a latathon body of hydroxy acid represented by the following general structural formula (2) having at least the following steps a ′ to c ′ or a hydrate thereof:
Figure imgf000015_0001
Figure imgf000015_0001
(2)  (2)
[式中、 Mは、アルカリ土類金属を表す。 ]  [Wherein M represents an alkaline earth metal. ]
工程 a,:ガルシニアエキスと、ガルシニアエキスに含まれる(一)一ヒドロキシクェン酸 に対してモル比で 0. 5倍以上 0. 9倍未満の範囲内のアルカリ土類金属酸ィ匕物又は アルカリ土類金属水酸ィ匕物若しくはその水和物とを反応させる工程、  Step a ,: Garcinia extract and (1) Alkaline earth metal oxide or alkali within a range of 0.5 times or more and less than 0.9 times in molar ratio with respect to monohydroxy quenate Reacting with an earth metal hydroxide or a hydrate thereof,
工程 b ':工程 a'の反応液を放置又は冷却することにより生成物を析出させる工程、 工程 c ':析出物を取得し、さらに取得した析出物を再結晶化する工程。  Step b ': a step of depositing a product by leaving or cooling the reaction solution of step a', step c ': a step of obtaining the precipitate and recrystallizing the obtained precipitate.
[9] ガノレシニアエキスが、ゴラカ(Garcinia cambogia)、インドマンゴスチン(Garcinia indica)又はグルグル (Garcinia atroviridis)の果皮から抽出して得られるもので ある、請求項 8記載の(一)ーヒドロキシクェン酸のラタトン体のアルカリ土類金属塩又 はその水和物の製造法。  [9] The (1) -hydroxycend according to claim 8, wherein the ganoressin extract is obtained by extracting from the peel of goraka (Garcinia cambogia), indomangosteen (Garcinia inrovica) or gurugur (Garcinia atroviridis). A method for producing alkaline earth metal salts or hydrates of acid ratatones.
[10] 工程 a'で使用するアルカリ土類金属酸ィ匕物が酸ィ匕カルシウムである、請求項 8又は 9の 、ずれかに記載の(一) ヒドロキシクェン酸のラタトン体のアルカリ土類金属塩 又はその水和物の製造法。  [10] The alkaline earth metal of the ratatones of (1) hydroxychenic acid according to any one of claims 8 or 9, wherein the alkaline earth metal oxide used in step a 'is acid calcium. A method for producing a metal salt or a hydrate thereof.
[11] 工程 a'で使用するアルカリ土類金属水酸ィ匕物又はその水和物が水酸ィ匕カルシウム 又はその水和物である、請求項 8又は 9のいずれかに記載の(一) 酸のラタトン体のアルカリ土類金属塩又はその水和物の製造法。 [11] Alkaline earth metal hydroxide or its hydrate used in step a 'is calcium hydroxide Or (1) a method for producing an alkaline earth metal salt of an acid ratatotone or a hydrate thereof according to any one of claims 8 and 9, which is a hydrate thereof.
PCT/JP2006/314024 2005-07-15 2006-07-14 Process for producing alkaline earth metal salt of (-)-hydroxycitric acid WO2007010838A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007525985A JP4998264B2 (en) 2005-07-15 2006-07-14 (-)-Method for producing alkaline earth metal salt of hydroxycitric acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005207259 2005-07-15
JP2005-207259 2005-07-15

Publications (1)

Publication Number Publication Date
WO2007010838A1 true WO2007010838A1 (en) 2007-01-25

Family

ID=37668719

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/314024 WO2007010838A1 (en) 2005-07-15 2006-07-14 Process for producing alkaline earth metal salt of (-)-hydroxycitric acid

Country Status (2)

Country Link
JP (1) JP4998264B2 (en)
WO (1) WO2007010838A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099413A3 (en) * 2007-02-16 2009-04-16 Vittal Mallya Scient Res Found High purity (-) hydroxycitric acid metal salt derivatives and method of preparation of the same
EP3762357A4 (en) * 2018-03-07 2021-12-08 Glykon Technologies Group, LLC Hydroxycitric acid metal heterocyclic compounds with covalent characteristics

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions
US20040229953A1 (en) * 2003-05-12 2004-11-18 Gokaraju Ganga Raju Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts
WO2004100682A1 (en) * 2003-05-19 2004-11-25 Indfrag Limited A novel composition of complex metal salt of garcinia acid, a process for preparing the same and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions
US20040229953A1 (en) * 2003-05-12 2004-11-18 Gokaraju Ganga Raju Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts
WO2004100682A1 (en) * 2003-05-19 2004-11-25 Indfrag Limited A novel composition of complex metal salt of garcinia acid, a process for preparing the same and use thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099413A3 (en) * 2007-02-16 2009-04-16 Vittal Mallya Scient Res Found High purity (-) hydroxycitric acid metal salt derivatives and method of preparation of the same
EP2125691A2 (en) * 2007-02-16 2009-12-02 Vittal Mallya Scientific Research Foundation High purity (-) hydroxycitric acid metal salt derivatives and method of preparation of the same
EP2125691A4 (en) * 2007-02-16 2012-02-01 Vittal Mallya Scient Res Foundation High purity (-) hydroxycitric acid metal salt derivatives and method of preparation of the same
EP3762357A4 (en) * 2018-03-07 2021-12-08 Glykon Technologies Group, LLC Hydroxycitric acid metal heterocyclic compounds with covalent characteristics
US11292759B2 (en) 2018-03-07 2022-04-05 Nutrition Research Group, Limited Hydroxycitric acid metal heterocyclic compounds with covalent characteristics
US11795187B2 (en) 2018-03-07 2023-10-24 Glykon Technologies Group, Llc Hydroxycitric acid metal heterocyclic compounds with covalent characteristics

Also Published As

Publication number Publication date
JP4998264B2 (en) 2012-08-15
JPWO2007010838A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
JP5214615B2 (en) Process for preparing halogenated N-alkylnaltrexone
CN108191749B (en) Preparation method of flonicamid and intermediate 4-trifluoromethyl nicotinic acid thereof
AU2013274407B2 (en) Improved method of preparing oxymorphone
EP2477975B1 (en) Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
TWI703163B (en) Method for preparing sugammadex sodium and crystalline form thereof
CN108794351A (en) A kind of preparation method of Mo Fanselin key intermediate
WO2007010838A1 (en) Process for producing alkaline earth metal salt of (-)-hydroxycitric acid
AU2019212668B2 (en) Crystalline forms of mesaconine and preparation method therefor
CA2942283C (en) Inclusion compound of 3&#39;,5&#39;-cyclic diadenylic acid and manufacturing method thereof
EP2643308B1 (en) Process for the preparation of taurolidine and its intermediates thereof
JP6124562B2 (en) 4 &#39;-[[2-n-propyl-4-methyl-6- (1-methylbenzimidazol-2-yl) -benzimidazol-1-yl] -methyl] -biphenyl-2-carboxylic acid ammonium salt crystal
CN111205285B (en) Purification method and crystal form of berberine or berberine salt
CN111039885B (en) Method for preparing high-purity combretastatin
CN114008023A (en) Crystal form of Sopyrazamine and preparation method thereof
WO2007063869A1 (en) Process for production of highly pure quinolone compound
JP2008510717A (en) Process for producing levorphanol and related compounds
CN104016884A (en) Synthetic method of calixarene derivative
JPS628118B2 (en)
CN114349690B (en) Synthesis method of doravirine intermediate
CN107365299B (en) Preparation method of dabigatran etexilate and intermediate thereof
CN106496096B (en) The synthetic method of unnatural tryptophan derivative
CN116554171A (en) Novel crystal form, application and preparation method of BRD4 inhibitor compound
JPS6212777A (en) Separation and purification of berberine alkaloid
CN118324747A (en) New process for preparing voronoi and intermediate thereof
JP2016053009A (en) Method for producing ammonium salt of telmisartan

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007525985

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06781098

Country of ref document: EP

Kind code of ref document: A1